Your browser is no longer supported. Please, upgrade your browser.
Nephros, Inc.
Index- P/E- EPS (ttm)-0.39 Insider Own1.70% Shs Outstand10.04M Perf Week-3.00%
Market Cap51.41M Forward P/E- EPS next Y-0.27 Insider Trans6.50% Shs Float8.93M Perf Month-19.17%
Income-3.80M PEG- EPS next Q-0.11 Inst Own52.30% Short Float0.24% Perf Quarter-33.75%
Sales10.00M P/S5.14 EPS this Y-15.80% Inst Trans0.02% Short Ratio1.51 Perf Half Y-48.03%
Book/sh1.22 P/B3.98 EPS next Y34.10% ROA-21.20% Target Price13.42 Perf Year-37.82%
Cash/sh0.70 P/C6.95 EPS next 5Y- ROE-31.10% 52W Range4.64 - 11.67 Perf YTD-17.80%
Dividend- P/FCF- EPS past 5Y8.10% ROI-31.40% 52W High-59.80% Beta1.18
Dividend %- Quick Ratio4.90 Sales past 5Y34.50% Gross Margin55.90% 52W Low1.08% ATR0.29
Employees27 Current Ratio7.50 Sales Q/Q23.80% Oper. Margin-36.20% RSI (14)24.24 Volatility5.01% 4.66%
OptionableNo Debt/Eq0.04 EPS Q/Q-2.60% Profit Margin-38.30% Rel Volume2.54 Prev Close4.85
ShortableYes LT Debt/Eq0.02 EarningsNov 04 AMC Payout- Avg Volume14.00K Price4.69
Recom2.00 SMA20-15.09% SMA50-26.78% SMA200-40.64% Volume14,588 Change-3.30%
Jan-26-21Initiated B. Riley Securities Buy $12.50
Jan-13-22 07:30AM  
Jan-11-22 07:30AM  
Nov-23-21 04:15PM  
Nov-08-21 07:30AM  
Nov-04-21 04:15PM  
Oct-21-21 07:30AM  
Oct-08-21 07:30AM  
Oct-05-21 07:30AM  
Sep-15-21 09:39AM  
Sep-06-21 11:42AM  
Sep-01-21 07:30AM  
Aug-05-21 04:15PM  
Jul-28-21 03:03PM  
Jul-12-21 07:30AM  
Jul-09-21 04:18PM  
Jul-08-21 11:20AM  
Jun-29-21 08:50AM  
Jun-23-21 09:35AM  
May-31-21 08:50AM  
May-06-21 04:15PM  
Apr-26-21 07:30AM  
Apr-09-21 05:29AM  
Apr-05-21 07:30AM  
Mar-16-21 07:45AM  
Mar-10-21 07:30AM  
Mar-04-21 02:07AM  
Mar-01-21 04:15PM  
Feb-22-21 07:30AM  
Feb-18-21 07:30AM  
Jan-22-21 02:21AM  
Jan-12-21 07:30AM  
Jan-05-21 10:55AM  
Jan-04-21 07:30AM  
Nov-29-20 09:33AM  
Nov-19-20 06:45AM  
Nov-09-20 07:30AM  
Nov-05-20 04:27PM  
Oct-29-20 07:30AM  
Oct-24-20 10:47AM  
Oct-16-20 07:30AM  
Oct-13-20 07:30AM  
Oct-07-20 07:30AM  
Oct-06-20 07:30AM  
Aug-31-20 05:00PM  
Aug-25-20 07:30AM  
Aug-14-20 07:30AM  
Aug-06-20 01:43PM  
Aug-05-20 04:15PM  
Jul-29-20 07:30AM  
Jul-22-20 07:30AM  
Jul-16-20 11:00AM  
Jul-14-20 07:30AM  
Jul-13-20 07:30AM  
Jul-08-20 07:30AM  
Jun-18-20 07:30AM  
Jun-10-20 01:44PM  
Jun-03-20 09:00AM  
Jun-02-20 07:30AM  
May-11-20 04:15PM  
May-06-20 04:15PM  
Apr-29-20 07:30AM  
Apr-08-20 07:08AM  
Apr-02-20 07:30AM  
Mar-25-20 07:30AM  
Mar-23-20 07:48AM  
Mar-19-20 08:54AM  
Mar-10-20 07:30AM  
Mar-04-20 04:45PM  
Mar-03-20 07:30AM  
Feb-27-20 04:05PM  
Feb-20-20 07:30AM  
Feb-12-20 09:26AM  
Jan-31-20 07:30AM  
Jan-09-20 07:30AM  
Jan-07-20 10:23AM  
Jan-06-20 07:30AM  
Dec-06-19 11:44AM  
Nov-06-19 07:30AM  
Oct-31-19 07:30AM  
Oct-23-19 11:12AM  
Oct-14-19 07:30AM  
Oct-07-19 07:30AM  
Sep-03-19 07:30AM  
Aug-17-19 09:18AM  
Aug-13-19 07:30AM  
Aug-07-19 04:05PM  
Jul-30-19 01:32PM  
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company operates through three segments: Water Filtration, Pathogen Detection, and Renal Products. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company develops and sells water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. Nephros, Inc. was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lobo Wesley S.Chief Marketing OfficerAug 20Buy7.921,0007,92041,557Aug 23 01:01 PM
Gwydir TomDirectorAug 18Buy7.645,00038,20011,031Aug 19 09:04 PM
Astor AndrewPresident & CEOAug 18Buy7.772,50019,43377,958Aug 18 06:08 PM
Astor AndrewPresident & CEOAug 17Buy7.672,50019,17275,458Aug 18 06:08 PM
WEXFORD CAPITAL LPDirectorJan 27Option Exercise4.2214,75462,260106,037Jan 29 04:49 PM